×
News Home

Ocuphire Pharma Inc (OCUP) Stock Decreases -9.42% This Week; Should You Buy?

Tuesday, March 29, 2022 01:20 PM | InvestorsObserver Analysts
Ocuphire Pharma Inc (OCUP) Stock Decreases -9.42% This Week; Should You Buy?

Ocuphire Pharma Inc (OCUP) stock is lower by -40.24% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives OCUP stock a score of 71 out of a possible 100.

That rank is chiefly influenced by a short-term technical score of 75. OCUP's rank also includes a fundamental score of 72. In addition to the average rating from Wall Street analysts, OCUP stock has a mean target price of $24.33. This means analysts expect the stock to rise 603.27% over the next 12 months. The long-term technical score for OCUP is 66.
Overall Score - 71
OCUP has an Overall Score of 71. Find out what this means to you and get the rest of the rankings on OCUP!

What's Happening with OCUP Stock Today

Ocuphire Pharma Inc (OCUP) stock has fallen -18.59% while the S&P 500 has gained 0.44% as of 1:18 PM on Tuesday, Mar 29. OCUP is lower by -$0.79 from the previous closing price of $4.25 on volume of 1,898,913 shares. Over the past year the S&P 500 is up 15.73% while OCUP is lower by -40.24%. OCUP lost -$3.82 per share in the over the last 12 months. Click Here to get the full Stock Report for Ocuphire Pharma Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App